首页|期刊导航|中国癌症杂志|直肠系膜筋膜状态及演变在行新辅助放化疗局部晚期直肠癌患者中的预后价值:一项回顾性研究

直肠系膜筋膜状态及演变在行新辅助放化疗局部晚期直肠癌患者中的预后价值:一项回顾性研究OA

Prognostic significance of mesorectal fascia status and its alterations in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy:a retrospective cohort study

中文摘要英文摘要

背景与目的:MRI提示的直肠系膜筋膜(mesorectal fascia,MRF)受侵是局部晚期直肠癌(locally advanced rectal cancer,LARC)高危的重要影像学标志.然而,在新辅助放化疗(neoadjuvant chemoradiotherapy,nCRT)背景下,其预后预测价值仍存在争议.本研究旨在评估MRF阳性状态及其动态转化对患者临床预后的影响.方法:回顾性分析2018年—2024年复旦大学附属肿瘤医院大肠外科收治的符合纳入和排除标准,接受了nCRT并行根治性手术的1 159例LARC患者的临床资料.根据患者基线MRF状态(阳性 vs 阴性)进行分组,并采用1∶2倾向评分匹配(propensity score matching,PSM)平衡临床病理学特征.采用Kaplan-Meier法及Cox回归分析评估无病生存期(disease-free survival,DFS)和总生存期(overall survival,OS),并在MRF阳性亚组内进行多因素分析以探讨影响患者预后的相关因素.本研究经复旦大学附属肿瘤医院伦理委员会批准(1807188-10-2001B)并获得患者知情同意.结果:本研究共纳入1 159例患者,其中270例(23.3%)患者MRF阳性.PSM匹配前,队列中MRF阳性患者的5年DFS率为73.2%,OS率为78.9%,显著低于MRF阴性组的86.7%和90.5%(P<0.001);经过1∶2的PSM匹配后,MRF阳性组的5年DFS率为70.4%,OS率为76.5%,仍显著低于MRF阴性组的84.1%和88.7%(P=0.002,P=0.004).在MRF阳性患者队列中,多因素分析显示,mrT4分期、mrN2分期及Miles/Hartmann术式为独立的不良预后因素,而MRF由阳转阴的影像学"转化"并未与患者的预后情况改善独立相关.在术前末次MRI评估为MRF阳性的患者中,病理学检查结果证实,环周切缘阳性者仅占7.2%,提示MRI对MRF的评估特异性有限.结论:MRI评估的MRF阳性状态仍是LARC患者不良预后的重要独立指标,PSM匹配后该结果依旧表现出显著性.然而,影像学MRF"转化"并不能独立预测患者的预后,且MRI提示MRF阳性病例的术后病理学检查结果仍可能显示阴性切缘.MRF阳性患者由于MRI评估MRF状态的局限性,应积极制定个体化评估策略,争取获得外科手术治疗的机会.

Background and purpose:Mesorectal fascia(MRF)involvement identified on MRI is a key imaging surrogate of high-risk disease in patients with locally advanced rectal cancer(LARC).However,its prognostic significance in the era of modern neoadjuvant chemoradiotherapy(nCRT)remains controversial.This study aimed to evaluate the prognostic impact of baseline MRF positivity and its dynamic"conversion"pattern on clinical outcomes and survival.Methods:This study retrospectively reviewed 1 159 consecutive LARC patients treated with nCRT followed by curative resection at the Department of Colorectal Surgery,Fudan University Shanghai Cancer Center between 2018 and 2024.Patients were categorized according to baseline MRF status(positive vs negative),and 1∶2 propensity score matching(PSM)was used to balance clinicopathological characteristics.Disease-free survival(DFS)and overall survival(OS)were analyzed using the Kaplan-Meier method and Cox regression models.Multivariable analyses were further performed within the MRF-positive subgroup to identify independent prognostic determinants.This study was approved by the Ethics Committee of the Cancer Hospital affiliated with Fudan University(1807188-10-2001B)and acquired informed consent.Results:Among the 1 159 included patients,270(23.3%)had MRF-positive disease.Before propensity score matching(PSM),the 5-year DFS rate of MRF-positive patients in the cohort was 73.2%,and the OS rate was 78.9%,both significantly lower than the 86.7%and 90.5%in the MRF-negative group(P<0.001).After 1:2 PSM matching,the 5-year DFS rate in the MRF-positive group was 70.4%,and the OS rate was 76.5%,still significantly lower than the 84.1%and 88.7%in the MRF-negative group(P=0.002,P=0.004).Within the MRF-positive subgroup,multivariable analysis identified mrT4 stage,mrN2 stage,and Miles/Hartmann procedures as independent adverse prognostic factors.Notably,radiologic"conversion"from positive to negative MRF was not independently associated with improved survival.Among patients with MRF-positive findings on preoperative MRI,only 7.2%had pathologically confirmed circumferential resection margin(CRM)involvement,indicating limited specificity of MRI for MRF assessment.Conclusions:MRI-defined MRF positivity remains a robust independent predictor of poor prognosis in LARC,even after PSM adjustment.However,radiologic MRF"conversion"does not independently predict survival outcomes,and most MRI-suspected MRF-positive cases ultimately achieve negative pathological margins.These findings highlight both the prognostic value and inherent limitations of MRI,emphasizing the need for integrated radiologic-pathologic evaluation when tailoring individualized treatment strategies for rectal cancer.

汤君哲;胡诗琪;陆振霆;骆大葵;万觉峰;李心翔;李清国

复旦大学附属肿瘤医院大肠外二科,复旦大学上海医学院肿瘤学系,上海 200032复旦大学附属肿瘤医院大肠外二科,复旦大学上海医学院肿瘤学系,上海 200032复旦大学附属肿瘤医院大肠外二科,复旦大学上海医学院肿瘤学系,上海 200032复旦大学附属肿瘤医院大肠外二科,复旦大学上海医学院肿瘤学系,上海 200032复旦大学附属肿瘤医院放射治疗科,复旦大学上海医学院肿瘤学系,上海 200032复旦大学附属肿瘤医院大肠外二科,复旦大学上海医学院肿瘤学系,上海 200032复旦大学附属肿瘤医院大肠外二科,复旦大学上海医学院肿瘤学系,上海 200032

医药卫生

局部晚期直肠癌直肠系膜筋膜新辅助放化疗预后回顾性研究多因素分析

Locally advanced rectal cancerMesorectal fasciaNeoadjuvant chemoradiotherapyPrognosisRetrospective studyMultivariable analysis

《中国癌症杂志》 2026 (2)

162-173,12

国家自然科学基金(82373090,82573111). National Natural Science Foundation of China(82373090,82573111).

10.19401/j.cnki.1007-3639.2026.02.008

评论